135 related articles for article (PubMed ID: 29394644)
1. [Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Bone Marrow Carcinomatosis Arising from Breast Cancer - A Case Report].
Nakayama I
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1391-1392. PubMed ID: 29394644
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Disseminated Bone Marrow Carcinomatosis Arising from Breast Cancer for Which Paclitaxel and Bevacizumab Treatment Was Effective].
Kamata A; Hagiwara H; Koizumi M; Sarukawa H; Wada Y; Miyamae T; Abe Y; Takahashi K; Kano T; Natori J; Uchiyama K
Gan To Kagaku Ryoho; 2016 Jan; 43(1):103-6. PubMed ID: 26809535
[TBL] [Abstract][Full Text] [Related]
3. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab].
Kawai H; Sugimoto R; Miyauchi S; Yoshida R; Waki N; Hirayama S; Ishizaki M; Nishi H; Yamashita K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388
[TBL] [Abstract][Full Text] [Related]
4. [A case of bone marrow carcinomatosis from breast cancer treated with weekly Paclitaxel].
Takayama S; Ueno H; Kawaguchi S; Asahara F; Hoshimoto S; Harada H; Ogawa S; Sato M; Matsui J; Ando N
Gan To Kagaku Ryoho; 2012 Jan; 39(1):99-101. PubMed ID: 22241360
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Microangiopathic Hemolytic Anemia with Bone Marrow Carcinomatosis from Breast Cancer].
Murakami A; Kamei Y; Kusakabe E; Yamasawa H; Aoki R; Komatsu S; Taguchi K; Nishiyama K; Yamashita M; Sugimori W; Asai H; Mizuno Y; Takada Y
Gan To Kagaku Ryoho; 2018 Jul; 45(7):1105-1107. PubMed ID: 30042282
[TBL] [Abstract][Full Text] [Related]
6. [Case Report of Long-Term Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Stage Ⅳ AdvancedBreast Cancer].
Sugimoto H; Miura T; Kawamura Y; Aburatani T; Hanaoka M; Ogo T; Hoshino N; Nishioka Y; Kawano T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2246-2248. PubMed ID: 32156893
[TBL] [Abstract][Full Text] [Related]
7. [A case of breast cancer with bone marrow and liver metastases responding completely to low-dose weekly paclitaxel combined with toremifene].
Momiyama N; Kameda K; Mochizuki Y; Natori S; Takekawa Y; Kubo A
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1287-9. PubMed ID: 11579642
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
Watanabe N; Furukawa J; Minoji T; Tamai K; Kitahara T; Yamamura N; Okamura S; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2018 Jul; 45(7):1097-1099. PubMed ID: 30042280
[TBL] [Abstract][Full Text] [Related]
9. [Breast Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine Monotherapy after Failure of Combination Therapy Comprising Bevacizumab and Paclitaxel].
Ooe A; Suganuma Y
Gan To Kagaku Ryoho; 2016 Mar; 43(3):349-51. PubMed ID: 27067853
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Zielinski C; Láng I; Inbar M; Kahán Z; Greil R; Beslija S; Stemmer SM; Zvirbule Z; Steger GG; Melichar B; Pienkowski T; Sirbu D; Petruzelka L; Eniu A; Nisenbaum B; Dank M; Anghel R; Messinger D; Brodowicz T;
Lancet Oncol; 2016 Sep; 17(9):1230-9. PubMed ID: 27501767
[TBL] [Abstract][Full Text] [Related]
11. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel.
Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
Gan To Kagaku Ryoho; 2014 May; 41(5):637-40. PubMed ID: 24917012
[TBL] [Abstract][Full Text] [Related]
12. [A case of stage IV breast cancer with long-term partial response treated with tri-weekly paclitaxel plus bevacizumab].
Okamoto A; Nakatsukasa K; Fujita Y; Sugimoto R; Sakaguchi K; Taguchi T
Gan To Kagaku Ryoho; 2015 Mar; 42(3):343-6. PubMed ID: 25812504
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.
Manso L; Palomo AG; Pérez Carrión R; Cassinello J; Gallegos Sancho I; Chacón López-Muñiz I; Olier C; Fernández-Aramburo A; Llorca C; González X; Llorente R; Torregrosa D; Álvarez I; Gálve E; Bueno C; Garau I; García MJ; González-Santiago S; Ballesteros AI; Blanco E; Galán A; González S; Perelló A; Cortés-Funes H; Grávalos C
Anticancer Res; 2015 Dec; 35(12):6941-50. PubMed ID: 26637920
[TBL] [Abstract][Full Text] [Related]
14. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
Tsubota Y; Sueoka N; Yamamoto D
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Drug-Induced Lung Injury Associated with Paclitaxel plus Bevacizumab Therapy].
Yamaguchi Y; Tada Y; Takaya S; Iwamoto A; Yamashiro Y; Shibata S; Ishiguro M; Nishidoi H
Gan To Kagaku Ryoho; 2016 Jun; 43(6):781-4. PubMed ID: 27306821
[TBL] [Abstract][Full Text] [Related]
16. [HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Senoo S; Mannami T; Tamura T; Fujiwara N; Ikeda G; Komoda M; Ohtawa Y; Fujimoto Y; Sato N; Kambara T; Waku T; Kenmotsu M; Kurimoto E; Okada T; Harita S; Sonobe H
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2471-5. PubMed ID: 26809307
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report].
Morishita A; Mitsuhashi S; Fujisawa F; Hirano M; Kojima H
Gan To Kagaku Ryoho; 2013 Jun; 40(6):761-4. PubMed ID: 23863653
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent breast cancer with bone marrow metastasis treated with weekly paclitaxel therapy].
Sasada S; Yokoyama G; Takahashi H; Koike K; Ikejiri K; Fujii T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1611-3. PubMed ID: 18799923
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.
Lang I; Brodowicz T; Ryvo L; Kahan Z; Greil R; Beslija S; Stemmer SM; Kaufman B; Zvirbule Z; Steger GG; Melichar B; Pienkowski T; Sirbu D; Messinger D; Zielinski C;
Lancet Oncol; 2013 Feb; 14(2):125-33. PubMed ID: 23312888
[TBL] [Abstract][Full Text] [Related]
20. [A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab].
Miki M; Matsuo Y; Yoshida S; Tane K; Hirokaga K; Maekawa Y; Takao S
Gan To Kagaku Ryoho; 2014 Aug; 41(8):1027-9. PubMed ID: 25132039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]